Vycor Medical Inc (VYCO)
VYCO is quoted over the counter, not listed on an exchange. Vycor Medical Inc files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-13.
Profile
| Field | Value |
|---|---|
| Ticker | VYCO, quoted over the counter |
| SEC CIK | 0001424768 |
| OTC Markets tier | OTCQB (price source, 2026-11-13) |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Business address | Boca Raton,, FL |
| Incorporated in | DE |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These conditions, among others, raise substantial doubt regarding our ability to continue as a going concern." | 10-Q 2026-11-13 |
| Cash and burn | $159K cash; operating cash flow $15K a quarter. | Report 2026-06-30 |
| Shares outstanding | 33,372,796 (2026-11-13); 33,372,796 a year earlier; 32,628,835 three years earlier. | Cover page 2026-11-13 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Prager Metis CPAs, LLC, Hackensack, New Jersey, United States | PCAOB Form AP 2026-04-10 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $418K | -$22K | -$5K | $159K | $304K | $1.8M | 10-Q 2026-08-14 |
| Q1 2026 2026-03-31 | $459K | $20K | $99K | $174K | $313K | $1.9M | 10-Q 2026-05-15 |
| Q4 2025 2025-12-31 | $417K | -$63K | $39K | $87K | $327K | $1.9M | 10-K 2026-03-31 |
| Q3 2025 2025-09-30 | $514K | $5K | -$72K | $64K | $341K | $1.9M | 10-Q 2025-11-14 |
| Q2 2025 2025-06-30 | $496K | $24K | $47K | $100K | $303K | $1.8M | 10-Q 2026-08-14 |
| Q1 2025 2025-03-31 | $436K | -$39K | -$27K | $61K | $308K | $1.7M | 10-Q 2026-05-15 |
| Q4 2024 2024-12-31 | $455K | -$7K | -$38K | $106K | $324K | $1.6M | 10-K 2026-03-31 |
| Q3 2024 2024-09-30 | $391K | -$60K | $10K | $158K | $337K | $1.4M | 10-Q 2025-11-14 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2016-10-21 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-11-13 |
| Latest current report | 8-K | 2026-11-16 |
Source: SEC EDGAR submissions feed, 464 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier